Artera AI’s Prostate Cancer Prognostication Tool

  • Our AI tool learns from patient-level clinical data and unannotated pathology slides to prognosticate long-term outcomes.
  • Using five NRG Oncology Phase III randomized clinical trials,we’ve trained and validated prognostic biomarkers in localized prostate cancer.

This manuscript has been accepted at npj Digital Medicine

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.

To learn more about using the Artera AI Prostate Prognostic tool,

please contact: info@artera.ai